532 related articles for article (PubMed ID: 7800480)
21. Differential effects of I kappa B molecules on Tat-mediated transactivation of HIV-1 LTR.
Harhaj E; Blaney J; Millhouse S; Sun SC
Virology; 1996 Feb; 216(1):284-7. PubMed ID: 8615004
[TBL] [Abstract][Full Text] [Related]
22. Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat.
Sawaya BE; Khalili K; Amini S
J Gen Virol; 1998 Feb; 79 ( Pt 2)():239-46. PubMed ID: 9472608
[TBL] [Abstract][Full Text] [Related]
23. Central nervous system-derived cells express a kappa B-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat.
Taylor JP; Pomerantz RJ; Raj GV; Kashanchi F; Brady JN; Amini S; Khalili K
J Virol; 1994 Jun; 68(6):3971-81. PubMed ID: 8189531
[TBL] [Abstract][Full Text] [Related]
24. TAR and Sp1-independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cytomegalovirus IE1/IE2.
Dal Monte P; Landini MP; Sinclair J; Virelizier JL; Michelson S
AIDS; 1997 Mar; 11(3):297-303. PubMed ID: 9147420
[TBL] [Abstract][Full Text] [Related]
25. Identification of limiting steps for efficient trans-activation of HIV-1 promoter by Tat in Saccharomyces cerevisiae.
Daviet L; Bois F; Battisti PL; Gatignol A
J Biol Chem; 1998 Oct; 273(43):28219-28. PubMed ID: 9774443
[TBL] [Abstract][Full Text] [Related]
26. Sp1 and related factors fail to interact with the NF-kappaB-proximal G/C box in the LTR of a replication competent, brain-derived strain of HIV-1 (YU-2).
Millhouse S; Krebs FC; Yao J; McAllister JJ; Conner J; Ross H; Wigdahl B
J Neurovirol; 1998 Jun; 4(3):312-23. PubMed ID: 9639074
[TBL] [Abstract][Full Text] [Related]
27. Regulation of human T-cell leukemia virus type 1 gene expression by Sp1 and Sp3 interaction with TRE-1 repeat III.
Yao J; Grant C; Harhaj E; Nonnemacher M; Alefantis T; Martin J; Jain P; Wigdahl B
DNA Cell Biol; 2006 May; 25(5):262-76. PubMed ID: 16716116
[TBL] [Abstract][Full Text] [Related]
28. The role of Sp1 family members, the proximal GC-rich motifs, and the upstream enhancer region in the regulation of the human cell cycle inhibitor p21WAF-1/Cip1 gene promoter.
Koutsodontis G; Moustakas A; Kardassis D
Biochemistry; 2002 Oct; 41(42):12771-84. PubMed ID: 12379120
[TBL] [Abstract][Full Text] [Related]
29. Novel transcriptional regulation of the human CYP3A7 gene by Sp1 and Sp3 through nuclear factor kappa B-like element.
Saito T; Takahashi Y; Hashimoto H; Kamataki T
J Biol Chem; 2001 Oct; 276(41):38010-22. PubMed ID: 11495920
[TBL] [Abstract][Full Text] [Related]
30. Basal and Tat-transactivated expression from the human immunodeficiency virus type 1 long terminal repeat in human placental trophoblast rules out promoter-enhancer activation as the partial block to viral replication.
Zachar V; Ebbesen P; Thomas RA; Zacharova V; Goustin AS
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1461-8. PubMed ID: 8207411
[TBL] [Abstract][Full Text] [Related]
31. Differences in transcriptional enhancers of HIV-1 and HIV-2. Response to T cell activation signals.
Tong-Starksen SE; Welsh TM; Peterlin BM
J Immunol; 1990 Dec; 145(12):4348-54. PubMed ID: 2258623
[TBL] [Abstract][Full Text] [Related]
32. Regulation of the human immunodeficiency virus type 1 long terminal repeat: interactions of thyroid hormone receptor with retinoid-X receptor, nuclear factor kappa B, Sp1, and Tat.
Desai-Yajnik V; Samuels HH
Trans Assoc Am Physicians; 1993; 106():13-32. PubMed ID: 8036737
[No Abstract] [Full Text] [Related]
33. Specificity of transcriptional regulation by the zinc finger transcription factors Sp1, Sp3, and Egr-1.
Al-Sarraj A; Day RM; Thiel G
J Cell Biochem; 2005 Jan; 94(1):153-67. PubMed ID: 15523672
[TBL] [Abstract][Full Text] [Related]
34. Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat.
Berkhout B; Jeang KT
J Virol; 1992 Jan; 66(1):139-49. PubMed ID: 1727476
[TBL] [Abstract][Full Text] [Related]
35. Cooperative inhibition of NF-kappa B and Tat-induced superactivation of human immunodeficiency virus type 1 long terminal repeat.
Biswas DK; Ahlers CM; Dezube BJ; Pardee AB
Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11044-8. PubMed ID: 8248210
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor.
Jeang KT; Chun R; Lin NH; Gatignol A; Glabe CG; Fan H
J Virol; 1993 Oct; 67(10):6224-33. PubMed ID: 7690421
[TBL] [Abstract][Full Text] [Related]
37. Synergistic activation of the human immunodeficiency virus type 1 promoter by the viral Tat protein and cellular transcription factor Sp1.
Kamine J; Chinnadurai G
J Virol; 1992 Jun; 66(6):3932-6. PubMed ID: 1583736
[TBL] [Abstract][Full Text] [Related]
38. Activation of the human immunodeficiency virus type 1 long terminal repeat by BTEB, a GC box-binding transcription factor.
Imataka H; Mizuno A; Fujii-Kuriyama Y; Hayami M
AIDS Res Hum Retroviruses; 1993 Sep; 9(9):825-31. PubMed ID: 8257632
[TBL] [Abstract][Full Text] [Related]
39. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.
Jeeninga RE; Hoogenkamp M; Armand-Ugon M; de Baar M; Verhoef K; Berkhout B
J Virol; 2000 Apr; 74(8):3740-51. PubMed ID: 10729149
[TBL] [Abstract][Full Text] [Related]
40. Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53.
Subler MA; Martin DW; Deb S
J Virol; 1994 Jan; 68(1):103-10. PubMed ID: 8254719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
